Prospective Observational Epidemiologic Study of Maraviroc's Safety
Trial ID or NCT#
NCT00665561
Status
NOT RECRUITING
Purpose
The study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.
Official Title
AN INTERNATIONAL, MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY OF THE SAFETY OF MARAVIROC USED WITH OPTIMIZED BACKGROUND THERAPY IN TREATMENT-EXPERIENCED HIV-1 INFECTED PATIENTS
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- * Treatment experienced, HIV-1 infected patients* 18 years or older* Receive an approved assay for determination of HIV-1 tropism
Exclusion Criteria:
- * Pregnant or lactating* Using CCR5 inhibitor other than maraviroc
Investigator(s)
Philip Grant
Positive care doctor,
Infectious diseases doctor
Clinical Associate Professor, Medicine - Infectious Diseases
Andrew Zolopa
Contact us to find out if this trial is right for you.
Contact
Debbie Slamowitz
(650) 723-2808
View on